Aidos Yerpashov

Aidos Yerpashov

Auto-generated profile, based on publicly available information

Aidos Yerpashov

Department of Cardiac Surgery, National Scientific Medical Center, Astana, Kazakhstan

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2024 in Наука и здравоохранение
Verified
Journal Article
Open access
AAAnuar Abdikarimov
Anuar Abdikarimov
ЕОЕ.д. Омаров
Е.д. Омаров
ССС.о. Сабербеков
С.о. Сабербеков
ЕМЕ.т. Мукантаев
Е.т. Мукантаев
АЕА.п. Ерпашов
А.п. Ерпашов
АТА. Төлегенұлы
А. Төлегенұлы
Введение: В Казахстане ежегодно выявляется более 1600 впервые в жизни установленных случаев злокачественных новообразований почек, а смертность составляет более 300 случаев. Характерной особенностью рака почки является формирование опухолевого тромбоза нижней полой вены (наблюдающееся с частотой до 25%), в ряде наблюдений распространяющегося на правое предсердие. В случае протяженного тромбоза нижней полой вены проблема эффективного лечения данной патологии становится особенно актуальной. Цель исследования: описать клинический случай успешного хирургического лечения почечно-клеточного рака левой почки, осложненного опухолевым тромбозом нижней полой вены и правого предсердия (IVтип), которое было выполнено впервые в Республике Казахстан. Клинический случай: Мужчина 56 лет госпитализирован в отделение общей и торакальной хирургии АО «ННМЦ» с диагнозом «рак левой почки» (сT3cN0M0, St III), осложненным опухолевым тромбозом нижней полой вены, правое предсердие (IV тип инвазии) и большими размерами опухоли левой почки. В плановом порядке пациенту выполнена операция в объеме: стернолапаротомия, радикальная нефрэктомия слева с тромбэктомией из нижней полой вены и правого предсердия, с резекцией правой печеночной вены, аортокавальная лимфодиссекция в условиях аппарата искусственного кровообращения. Кровопотеря составила 2000 мл. Ишемии печени не было. Общая длительность операции составила 525 минут. Послеоперационный период протекал гладко, без осложнений. Больной был выписан из стационара на 12-е сутки после операции. Выводы: Хирургический доступ при опухолевых инвазиях нижней полой вены (особенно типов III-IV) должен быть удобным, адекватным, создающим удобство экспозиции как правого предсердия, так и самой нижней полой вены на всем протяжении. В случае опухолевой инвазии устья нижней полой вены и правого предсердия, использование аппарата искусственного кровообращения с забором крови в кардиотомный резервуар коронарными отсосами делает тромбэктомию безопасной в плане геморрагических осложнений. Однако показания к применению такой процедуры – варианты подключения аппарата искусственного кровообращения, уровень гипотермии – требуют уточнения. Introduction: In Kazakhstan, more than 1,600 cases of malignant renal neoplasms are diagnosed annually, and the mortality rate is more than 300 cases. A characteristic feature of kidney cancer is the formation of tumor thrombosis of the inferior vena cava (observed with a frequency of up to 25%), in some cases extending to the right atrium. In the case of extended thrombosis of the inferior vena cava, the problem of effective treatment of this pathology is especially relevant. Objective of the study: To describe a clinical case of successful surgical treatment of renal cell carcinoma of the left kidney, complicated by tumor thrombosis of the inferior vena cava and right atrium (type IV), which was performed for the first time in the Republic of Kazakhstan. Clinical case: A 56-year-old man was hospitalized in the Department of General and Thoracic Surgery of JSC "NSMC" with a diagnosis of "left kidney cancer" (cT3cN0M0, St III), complicated by tumor thrombosis of the inferior vena cava to the tricuspid valve in the right atrium (IV type of invasion) and a large tumor in the left kidney. The patient underwent a planned operation as follows: sternolaparotomy, radical nephrectomy on the left with thrombectomy from the inferior vena cava and right atrium, aortocaval lymph node dissection under artificial circulation. Blood loss was 2000 ml. There was no liver ischemia. The total duration of the operation was 525 minutes. The postoperative period was uneventful, without complications. The patient was discharged from the hospital on the 12th day after the operation. Conclusions: Surgical access for tumor invasions of the inferior vena cava (especially types III-IV) must be convenient and adequate, creating convenient access to both the right atrium and the inferior vena cava itself along its entire length. In case of tumor invasion of the inferior vena cava orifice and the right atrium, the use of a heart-lung apparatus with blood flow contour through a cardiotomy reservoir by...

14 October 2026 in Journal of Clinical Medicine of Kazakhstan
Verified
Journal Article
Open access
AYAlimzhan Yelzhassov
Alimzhan Yelzhassov
Almas TolegenulyAlmas Tolegenuly
Almas Tolegenuly
AYAidos Yerpashov
Aidos Yerpashov
SLSergey Leontyev
Sergey Leontyev
ACAssel Chinybayeva
Assel Chinybayeva
AAAdil Abdinurov
Adil Abdinurov
Intraoperative graft assessment during coronary artery bypass grafting (CABG) aims to identify technical anastomotic defects before chest closure. Transit-time flow measurement (TTFM) and indocyanine green (ICG) fluorescence imaging represent complementary intraoperative assessment modalities, yet their comparative diagnostic performance against angiographic reference standards remains incompletely defined. PubMed, Scopus, Web of Science Core Collection, and CENTRAL were searched from January 2000 to February 2026 using terms for CABG, ICG, and TTFM; duplicate screening yielded κ = 0.86–0.91. Eligible studies evaluated ICG and/or TTFM against invasive coronary angiography or computed tomography coronary angiography. Methodological quality was appraised using QUADAS-2 for diagnostic cohorts and the Newcastle-Ottawa Scale (NOS) for clinical-utility cohorts. Because only three directly comparable cohorts provided sufficiently reliable paired 2×2 data, formal bivariate random-effects meta-analysis was not performed. Verified 2×2 contingency data were summarised descriptively with exact Clopper–Pearson 95% confidence intervals. Clinical-utility evidence was synthesised narratively. Eighteen unique primary clinical studies were included. Three studies (Desai et al., 2006; Yamamoto et al., 2015; Hatada et al., 2011), comprising 293 paired bypass grafts, provided directly comparable quantitative evidence. ICG demonstrated an aggregate descriptive sensitivity of 76.0% (95% CI, 54.9%–90.6%) and specificity of 99.3% (95% CI, 97.3%–99.9%). TTFM/flowmetry demonstrated aggregate sensitivity of 24.0% (95% CI, 9.4%–45.1%) and specificity of 96.3% (95% CI, 93.2%–98.2%). Formal between-modality P values were not calculated. The aggregate flowmetry estimate includes one cohort using experimental FFT-based waveform analysis (Hatada et al., 2011) and should be interpreted with caution. NOS assessment of six Tier 3 clinical-utility studies yielded scores of 5–9/9; no study provided a complete two-arm comparison with non-zero revision events in both arms, precluding pooled effect estimation. ICG fluorescence imaging showed higher descriptive sensitivity than TTFM/flowmetry for detecting structural graft abnormalities. A complementary approach combining quantitative flow assessment with selective fluorescence imaging may be considered in appropriately selected situations. Prospective multicenter studies are required before definitive recommendations can be made.